225 related articles for article (PubMed ID: 25123755)
1. The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial.
Mottl AK; Pajewski N; Fonseca V; Ismail-Beigi F; Chew E; Ambrosius WT; Greven C; Schubart U; Buse J
J Diabetes Complications; 2014; 28(6):874-9. PubMed ID: 25123755
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
7. To Study the Incidence of Diabetic Retinopathy in Different Stages of Diabetic Nephropathy in Type 2 Diabetes Mellitus.
Gopinath M; N PR; Hafeez M; An R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443361
[TBL] [Abstract][Full Text] [Related]
8. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial.
Gerstein HC; Ambrosius WT; Danis R; Ismail-Beigi F; Cushman W; Calles J; Banerji M; Schubart U; Chew EY;
Diabetes Care; 2013 May; 36(5):1266-71. PubMed ID: 23238658
[TBL] [Abstract][Full Text] [Related]
9. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
[TBL] [Abstract][Full Text] [Related]
10. Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2.
Kotlarsky P; Bolotin A; Dorfman K; Knyazer B; Lifshitz T; Levy J
Int Ophthalmol; 2015 Feb; 35(1):59-66. PubMed ID: 25391917
[TBL] [Abstract][Full Text] [Related]
11. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
[TBL] [Abstract][Full Text] [Related]
12. Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.
Tong PC; Kong AP; So WY; Yang X; Ng MC; Ho CS; Ma RC; Ozaki R; Ng V; Chow CC; Lam CW; Chan JC; Cockram CS
Diabet Med; 2007 Jul; 24(7):741-6. PubMed ID: 17403120
[TBL] [Abstract][Full Text] [Related]
13. The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes.
Wang Q; Cheng H; Jiang S; Zhang L; Liu X; Chen P; Liu J; Li Y; Liu X; Wang L; Li Z; Cai G; Chen X; Dong Z
Front Endocrinol (Lausanne); 2024; 15():1292412. PubMed ID: 38344659
[TBL] [Abstract][Full Text] [Related]
14. The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.
Menne J; Ritz E; Ruilope LM; Chatzikyrkou C; Viberti G; Haller H
J Am Heart Assoc; 2014; 3(2):e000810. PubMed ID: 24772521
[TBL] [Abstract][Full Text] [Related]
15. Association of diabetic retinopathy with risk of developing cardiovascular diseases in patients undergoing hemodialysis: A population-based cohort study.
Chu TW; Hsieh TH; Lin TY; Hung SC
Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1565-1573. PubMed ID: 37246078
[TBL] [Abstract][Full Text] [Related]
16. Long-term mortality and retinopathy in type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
[TBL] [Abstract][Full Text] [Related]
17. Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
Bethel MA; Mentz RJ; Merrill P; Buse JB; Chan JC; Goodman SG; Iqbal N; Jakuboniene N; Katona B; Lokhnygina Y; Lopes RD; Maggioni AP; Ohman P; Tankova T; Bakris GL; Hernandez AF; Holman RR
Diabetes Care; 2020 Feb; 43(2):446-452. PubMed ID: 31757838
[TBL] [Abstract][Full Text] [Related]
18. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
19. Association between Diabetes Complications and the Triglyceride-Glucose Index in Hospitalized Patients with Type 2 Diabetes.
Pan Y; Zhong S; Zhou K; Tian Z; Chen F; Liu Z; Geng Z; Li S; Huang R; Wang H; Zou W; Hu J
J Diabetes Res; 2021; 2021():8757996. PubMed ID: 34671683
[TBL] [Abstract][Full Text] [Related]
20. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
